Snowball logo
logo
PVLA

Palvella Therapeutics, Inc

PVLA β€’ NASDAQ
$145.75+$3.71Β  (2.61%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
31.4225.9----
COGS
2.3682.78----
Gross Profit
29.0523.12----
Operating Expenses & Income
Operating Income
(51.83)(43.47)(11.87)(14.1)(38.6)(57.74)
Total Operating Expenses
80.8866.611.8714.138.657.74
R&D Expenses
64.250.218.7938.15122.8435.46
Selling General & Admin Expenses
-4.1563.0765.94415.7622.29
Earnings from Continuing Operations
Interest Expense
---(4.317)(5.818)(7.596)
Interest Income
--6.2650.6422.594.186
Income Tax Expense
-(1.026)----
Net Income
Net Income
(45.74)(33.28)18.69(17.43)(41.72)(61.7)
Supplemental
EBIT
(45.74)(33.28)(11.87)(14.1)--
EBITDA
(43.37)(30.5)18.69(13.12)(35.9)(50)
In millions of USD, except % and values per 1 share